Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Giovanella, Luca (AUTHOR); Milan, Lisa (AUTHOR); Roll, Wolfgang (AUTHOR); Weber, Manuel (AUTHOR); Schenke, Simone (AUTHOR); Kreissl, Michael (AUTHOR); Vrachimis, Alexis (AUTHOR); Pabst, Kim (AUTHOR); Murat, Tuncel (AUTHOR); Petranovic Ovcaricek, Petra (AUTHOR); Riemann, Burkhard (AUTHOR); Ceriani, Luca (AUTHOR); Campenni, Alfredo (AUTHOR); Görges, Rainer (AUTHOR)
- Source:
European Journal of Nuclear Medicine & Molecular Imaging. Jul2023, Vol. 50 Issue 9, p2767-2774. 8p. 1 Diagram, 6 Charts.
- Additional Information
- Subject Terms:
- Abstract:
Purpose: An accurate postoperative assessment is pivotal to inform postoperative 131I treatment in patients with differentiated thyroid cancer (DTC). We developed a predictive model for post-treatment whole-body scintigraphy (PT-WBS) results (as a proxy for persistent disease) by adopting a decision tree model. Methods: Age, sex, histology, T stage, N stage, risk classes, remnant estimation, TSH, and Tg were identified as potential predictors and were put into regression algorithm (conditional inference tree, ctree) to develop a risk stratification model for predicting the presence of metastases in PT-WBS. Results: The lymph node (N) stage identified a partition of the population into two subgroups (N-positive vs N-negative). Among N-positive patients, a Tg value > 23.3 ng/mL conferred a 83% probability to have metastatic disease compared to those with lower Tg values. Additionally, N-negative patients were further substratified in three subgroups with different risk rates according to their Tg values. The model remained stable and reproducible in the iterative process of cross validation. Conclusions: We developed a simple and robust decision tree model able to provide reliable informations on the probability of persistent/metastatic DTC after surgery. These information may guide post-surgery 131I administration and select patients requiring curative rather than adjuvant 131I therapy schedules. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of European Journal of Nuclear Medicine & Molecular Imaging is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.